Evotec - Research never stops
  • Loading...

Hypha Discovery

Hypha currently has access to over 2,500 strains of higher basidiomycete and ascomycete fungi, many from South American and South East Asian rainforests. The MycoDiverse™ collection, which is unexploited in most therapeutic areas, contains samples of high chemical novelty. For further information, please click here.

Evotec is able to provide its screening clients with access to Hypha’s MycoDiverse™ natural product collection for use as part of its hit and lead identification services. Furthermore, following screening, Evotec could leverage its capabilities and expertise in natural product chemistry and medicinal chemistry to optimise promising hit compounds.